|
Volumn 11, Issue 8 Suppl 8, 1997, Pages 34-36
|
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOCETAXEL;
DRUG DERIVATIVE;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
TAXOID;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COLON TUMOR;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
FEVER;
HEAD AND NECK TUMOR;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
NEOPLASM;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PREMEDICATION;
REMISSION;
SARCOMA;
ADENOCARCINOMA;
ADULT;
AGED;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II;
COLONIC NEOPLASMS;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FEVER;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEAD AND NECK NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
NEOPLASMS;
NEUTROPENIA;
PACLITAXEL;
PREMEDICATION;
REMISSION INDUCTION;
SARCOMA;
TAXOIDS;
|
EID: 0031204210
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|